Market research
8CT.F Cannabix Technologies Inc
F EUR Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 35M
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.53
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- CA13765L1013
- Market cap
- 35M
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.53
About
About Cannabix Technologies Inc
Cannabix Technologies Inc. develops marijuana and alcohol breathalyzer technologies for law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) system for tetrahydrocannabinol (THC) detection and quantification, which includes the Cannabix Breath Collection Unit (BCU) and Breath Cartridge (BC) for non-invasive, portable, standardized human breath sample collection, storage, and transportation. The company also provides BreathLogix, an autonomous alcohol screening system for rapid and repeatable high-volume screening in various employment settings. In addition, the company develops other TCH-detecting technologies, including mass spectrometer breath sampler (MSBS) technology, as well as high-field asymmetric waveform ion mobility spectrometry (FAIMS) and FAIMS-mass spectrometer systems. It has a strategic partnership and development agreement with Omega Laboratories Inc. for the development and commercialization of MBT technology. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.
Research context
Cannabix Technologies Inc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 8CT.F discussion.
5 years, 7 months ago
Cannabix Technologies Inc is currently in a long term uptrend where the price is trading 11.2% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Cannabix Technologies Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 1271.4% to $-7M since the same quarter in the previous year.
Finally, its free cash flow fell by 5.5% to $-518K since the same quarter in the previous year.
Based on the above factors, Cannabix Technologies Inc gets an overall score of 2/5.